Global Taxanes Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Taxanes Market Research Report 2024
Taxane drugs are a series of derivatives synthesized by isolating anti-tumor active ingredients from plants and modifying the structure of the compounds of the active ingredients. They are mainly used in the field of chemotherapy for cancer treatment. Taxane drugs mainly include paclitaxel and its modified preparations, docetaxel and its modified preparations, cabazitaxel and derivatives with a taxane skeleton structure.
According to Mr Accuracy reports’s new survey, global Taxanes market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Taxanes market research.
Key manufacturers engaged in the Taxanes industry include Bristol Myers Squibb, Sanofi, Celgene Corporation, Pfizer, Biological E., Taj Accura, Khandeiwal Laboratories, Jiangsu Chia Tai-Tianqing Pharmaceutical and Nanjing Sike Medicine Industry, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Taxanes were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Taxanes market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Taxanes market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Bristol Myers Squibb
Sanofi
Celgene Corporation
Pfizer
Biological E.
Taj Accura
Khandeiwal Laboratories
Jiangsu Chia Tai-Tianqing Pharmaceutical
Nanjing Sike Medicine Industry
Shanghai Yizhong Pharmaceutical
QILU Pharmaceutical
Segment by Type
Paclitaxel
Docetaxel
Cabazitaxel
Taxane Derivatives
Others
Ovarian Cancer
Breast Cancer
Non-small Cell Lung Cancer
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Taxanes report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Taxanes market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Taxanes market research.
Key manufacturers engaged in the Taxanes industry include Bristol Myers Squibb, Sanofi, Celgene Corporation, Pfizer, Biological E., Taj Accura, Khandeiwal Laboratories, Jiangsu Chia Tai-Tianqing Pharmaceutical and Nanjing Sike Medicine Industry, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Taxanes were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Taxanes market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Taxanes market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bristol Myers Squibb
Sanofi
Celgene Corporation
Pfizer
Biological E.
Taj Accura
Khandeiwal Laboratories
Jiangsu Chia Tai-Tianqing Pharmaceutical
Nanjing Sike Medicine Industry
Shanghai Yizhong Pharmaceutical
QILU Pharmaceutical
Segment by Type
Paclitaxel
Docetaxel
Cabazitaxel
Taxane Derivatives
Others
Segment by Application
Ovarian Cancer
Breast Cancer
Non-small Cell Lung Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Taxanes report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source